Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VISUPLAIN 0,1MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/VISUPLAIN 0,1MG/ML COLIRIO EN SOLUCION

Approved

STANDARD

VISUPLAIN 0,1MG/ML COLIRIO EN SOLUCION

Visufarma S.P.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 24, 2022
Approval ID: b030ec91dfca7569
Company: Visufarma S.P.A.
Type: Standard

Approval Details

Approval Id: b030ec91dfca7569
Drug Cima Aemps Name: VISUPLAIN 0,1MG/ML COLIRIO EN SOLUCION
Register Number: 86578
Holder Company Name: Visufarma S.P.A.
Marketing Company Name: Visufarma S.P.A.
Authorization Date: 2022-02-24
Dosage Form: COLIRIO EN SOLUCIÓN
Dose: 0,1 mg/ml
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Visufarma S.P.A.

Active Ingredients

BIMATOPROST

0,1 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 24, 2022

Approval ID

b030ec91dfca7569

Type

Standard

Back to CIMA-AEMPS Approvals